Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 7, Number 3—June 2001

Research

Melioidosis: An Emerging Infection in Taiwan?

Po-Ren Hsueh*, Lee-Jene Teng*, Li-Na Lee*†, Cheong-Ren Yu*, Pan-Chyr Yang*, Shen-Wu Ho*†, and Kwen-Tay Luh*Comments to Author 
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan; †National Taiwan University College of Medicine, Taipei, Taiwan

Main Article

Table 2

Susceptibilities and antibiotypes of 17 isolates of Burkholderia pseudomallei isolated in Taiwan from November 1996 to January 2000

MIC (μg/mL) a
Patient no./isolate AM AMC PZP CTX CAZ FEP FLO ATM IPM MEM AN CIP TRO MOX Antibiotic type
8/A 64 8 0.5 4 4 16 128 16 0.5 1 64 2 2 2 I
9/B 64 8 1 4 4 16 128 16 0.5 1 128 2 2 2 I
10/C1, 2 64 8 0.5 4 4 16 128 16 0.5 1 32 1 2 2 II
11/D1, 2, 3, 4, 5 64 8 0.5 2 1 16 128 16 0.5 1 32 2 4 1 III
12/E1, 2 64 8 0.5 2 1 8 128 16 0.5 1 32 2 4 1 III
13/F1, 2, 3 64 8 0.5 2 1 16 128 16 0.5 1 16 2 4 1 III
14/G 16 2 0.12 2 1 8 64 8 0.25 0.5 64 1 1 1 IV
15/H1, 2 64 8 1 16 32 64 128 32 0.5 2 >256 4 8 4 V

aAM, amoxicillin; AMC, amoxicillin-clavulanate; PZP, piperacillin-tazobactam; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; FLO, flomoxef; ATM, aztreonam; IPM, imipenem; MEM, meropenem; AN, amikacin; CIP, ciprofloxacin; TRO, trovafloxacin; MOX, moxifloxacin.

Main Article

TOP